The ‘top-notch’ London-based group at Mathys & Squire LLP is well-equipped to assist in matters spanning sectors from life sciences and chemistry to IT and tech. Its workload incorporates managing the portfolios of large corporations, start-ups, Universities, NGOs and more, as well as assisting with granting and filing, with IP strategising and with EPO opposition matters. Chemistry specialist Chris Hamer leads the offering alongside ’standout’ engineering expert Paul Cozens, Cambridge-based Alan MacDougall who has notable tech expertise, and Martin MacLean who manages portfolios for corporate and government bodies, in particular. The four co-lead the offering. Oliver Parish is noted for his ‘excellent technical knowledge’.
Legal 500 Editorial commentary
Accolades
Client satisfaction: Lawyer & team quality
Client satisfaction: Billing & efficiency
Client satisfaction: Sector knowledge
Testimonials
Collated independently by Legal 500 research team.
- ‘Dani Kramer is a pleasure to work with. He is sharp, provides excellent and cost-effective advice and professional services.’
- ‘Paul Cozens as a standout partner, and Oliver Parish has impressive technical knowledge.’
- 'They have exceptional experience and expertise.'
- ‘Very skilled and knowledgeable.'
- ‘The Mathys team is easy and a joy to work with. They have the experience and requisite background to digest complex scientific matters and undertake well-done patent prosecution. I quite enjoy strategizing together and our collaborative efforts. They are pleasant and appropriate in communications, as well as responsive.’
- 'They are a go to firm for EPO consultation.'
- ‘Sean Leach is highly skilled technically, a great communicator, an excellent patent attorney, very experienced and very responsive.’
- ‘I work with the team around partner Sean Leach, who is exceptionally responsive and technically highly competent, as is his team. Pleasant to work with, always transparent, flexible - highly recommended.’
- 'They are absolutely committed to working with the customer. James Pitchford is outstanding with his knowledge and ability to apply it to IP writing.’
- ‘Fantastic team work from an absolutely top-notch team.’
Key clients
- Axogen Corporation
- NewSierra Medical Limited
- NewLIfT BioSciences, Ltd.
- NewAAK AB
- NewThe Broad Institute
- NewTigris Systems Limited
Work highlights
Acting as an anonymous “strawman” opponent on behalf of a major client in the pharmaceutical sector, Mathys & Squire successfully opposed European patent EP3681483 owned by Amgen, Inc.
Advised AAK in European Patent Office opposition appeal proceedings concerning infant formula compositions. Chris Hamer and Matthew Morton successfully overturned the initial decision, with the Board of Appeal finding the patent insufficient, lacking novelty and inventive step. The outcome removed a significant barrier to market activity, preserving AAK’s commercial position in a key sector.
Advised LIfT BioSciences on developing a global patent portfolio for its neutrophil-based cell therapy platform, with David Hobson and Danielle Champagne implementing a multi-layered IP strategy to address the complexities of cell-based therapies. The portfolio has secured key international patents and supported significant funding, strengthening the company’s market position and enabling progression into clinical development.
Other key lawyers
Christopher Hamer
Alan MacDougall
Max Thoma
NewAndrew White
NewAndrea McShane
NewAnna Gregson
NewDylan Morgan
NewMichael Stott
NewDavid Hobson
NewStephen Garner